Outcome = three-year MRI cartilage score | |||||
---|---|---|---|---|---|
Parameter | Estimate | SE | t | Pr > |t| | R2 |
RA duration (years) | 0.04 | 0.01 | 4.38 | 0.0002 | 0.42 |
Sex F (ref = M) | −1.67 | 3.26 | −0.51 | 0.61 | 0.01 |
Age | 0.13 | 0.11 | 1.22 | 0.23 | 0.05 |
DAS28CRP | 2.39 | 1.52 | 1.57 | 0.1282 | 0.09 |
Anti-CCP positive | 0.00 | 0.02 | 0.25 | 0.8056 | 0.00 |
HAQ | 3.06 | 2.28 | 1.34 | 0.1913 | 0.06 |
MRI cartilage score | 0.77 | 0.11 | 7.32 | <.0001 | 0.67 |
MRI erosion score | 0.52 | 0.11 | 4.77 | <.0001 | 0.47 |
MRI bone oedema score | 0.67 | 0.16 | 4.11 | 0.0004 | 0.39 |
MRI synovitis score | 3.04 | 0.78 | 3.90 | 0.0006 | 0.37 |
Outcome = 3 year MRI erosion score | |||||
RA duration (years) | 0.06 | 0.01 | 5.62 | <.0001 | 0.55 |
Sex F (ref = M) | -2.89 | 4.32 | -0.67 | 0.50 | 0.02 |
Age | 0.35 | 0.13 | 2.71 | 0.01 | 0.22 |
DAS28CRP | 0.21 | 2.11 | 0.10 | 0.92 | 0.00 |
Anti-CCP positive | -0.03 | 0.02 | -1.41 | 0.17 | 0.07 |
HAQ | 1.96 | 3.11 | 0.63 | 0.53 | 0.02 |
MRI cartilage score | 0.88 | 0.18 | 4.98 | <.0001 | 0.49 |
MRI erosion score | 0.95 | 0.07 | 13.15 | <.0001 | 0.87 |
MRI bone oedema score | 1.20 | 0.15 | 7.98 | <.0001 | 0.71 |
MRI synovitis score | 5.34 | 0.78 | 6.85 | <.0001 | 0.64 |